A Prospective Study on Direct Out-of-pocket Expenses of Hospitalized Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in a Philippine Tertiary Care Center

Overview

Journal BMC Pulm Med

Publisher Biomed Central

Specialty Pulmonary Medicine

Date 2024 Apr 17

PMID 38632584

Authors

Blake Warren Ang

Lenora Fernandez

Affiliations

Soon will be listed here.

Abstract

Chronic obstructive pulmonary disease (COPD) is a frequent cause of morbidity and mortality in the Philippines and majority of the economic burden lies in hospitalizations during an exacerbation. Despite coverage of hospitalization cost with the national health insurance system (Phil-Health) for COPD exacerbations, patients often pay out-of-pocket. This study aimed to determine the demographic characteristics of COPD admissions at a Philippine tertiary care center, Philippine General Hospital, and assess mean cost of hospitalization, and identify predictors of prolonged hospitalization and cost > 20,000 Philippine pesos (Php). A prospective cross-sectional study was conducted for 6 months by chart review. Patients were categorized as charity service patients, that is, with no charged professional fees and free medications and private service patients who pay for their health care services. A total of 43 COPD admissions were included. The average daily cost of hospitalization (at peso-dollar rate of 56) for service patients was at $ 75.89 compared to private service patients at $ 285.71. Demographic characteristics and type of accommodation were not significant predictors of prolonged hospital stay nor hospitalization cost of ≥ $ 357. Accommodation cost and professional fees accounted for majority or 61.6% of the overall cost for private patients, while medications and diagnostic tests were the major or 76.01% contributor to the overall cost for charity patients. Despite existence of Phil-health, in-patient coverage for COPD remain insufficient. Measures for maximizing COPD control in the out-patient setting could potentially reduce total cost for this disease.

References

Beran D, Zar H, Perrin C, Menezes A, Burney P . Burden of asthma and chronic obstructive pulmonary disease and access to essential medicines in low-income and middle-income countries. Lancet Respir Med. 2015; 3(2):159-170. DOI: 10.1016/S2213-2600(15)00004-1. View

Buist A, McBurnie M, Vollmer W, Gillespie S, Burney P, Mannino D . International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007; 370(9589):741-50. DOI: 10.1016/S0140-6736(07)61377-4. View

Vos T, Flaxman A, Naghavi M, Lozano R, Michaud C, Ezzati M . Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2163-96. PMC: 6350784. DOI: 10.1016/S0140-6736(12)61729-2. View

Miravitlles M, Guerrero T, Mayordomo C, Nicolau F, Segu J . Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. The EOLO Study Group. Respiration. 2000; 67(5):495-501. DOI: 10.1159/000067462. View

Lim S, Lam D, Razak Muttalif A, Yunus F, Wongtim S, Lan L . Impact of chronic obstructive pulmonary disease (COPD) in the Asia-Pacific region: the EPIC Asia population-based survey. Asia Pac Fam Med. 2015; 14(1):4. PMC: 4416253. DOI: 10.1186/s12930-015-0020-9. View

Ford E, Murphy L, Khavjou O, Giles W, Holt J, Croft J . Total and state-specific medical and absenteeism costs of COPD among adults aged ≥ 18 years in the United States for 2010 and projections through 2020. Chest. 2014; 147(1):31-45. DOI: 10.1378/chest.14-0972. View

Lopez-Campos J, Tan W, Soriano J . Global burden of COPD. Respirology. 2015; 21(1):14-23. DOI: 10.1111/resp.12660. View

Pena V, Miravitlles M, Gabriel R, Jimenez-Ruiz C, Villasante C, Masa J . Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest. 2000; 118(4):981-9. DOI: 10.1378/chest.118.4.981. View

Jones R, Dickson-Spillmann M, Mather M, Marks D, Shackell B . Accuracy of diagnostic registers and management of chronic obstructive pulmonary disease: the Devon primary care audit. Respir Res. 2008; 9:62. PMC: 2531184. DOI: 10.1186/1465-9921-9-62. View

10.

Torabipour A, Hakim A, Angali K, Dolatshah M, Yusofzadeh M . Cost Analysis of Hospitalized Patients with Chronic Obstructive Pulmonary Disease: A State-Level Cross-Sectional Study. Tanaffos. 2016; 15(2):75-82. PMC: 5127618. View

11.

Langhammer A, Johannessen A, Holmen T, Melbye H, Stanojevic S, Lund M . Global Lung Function Initiative 2012 reference equations for spirometry in the Norwegian population. Eur Respir J. 2016; 48(6):1602-1611. DOI: 10.1183/13993003.00443-2016. View

12.

Wang Y, Stavem K, Dahl F, Humerfelt S, Haugen T . Factors associated with a prolonged length of stay after acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Int J Chron Obstruct Pulmon Dis. 2014; 9:99-105. PMC: 3901775. DOI: 10.2147/COPD.S51467. View

13.

Wouters E . Economic analysis of the Confronting COPD survey: an overview of results. Respir Med. 2003; 97 Suppl C:S3-14. DOI: 10.1016/s0954-6111(03)80020-3. View

14.

Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V . Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2095-128. PMC: 10790329. DOI: 10.1016/S0140-6736(12)61728-0. View

15.

Gutierrez Villegas C, Paz-Zulueta M, Herrero-Montes M, Paras-Bravo P, Madrazo Perez M . Cost analysis of chronic obstructive pulmonary disease (COPD): a systematic review. Health Econ Rev. 2021; 11(1):31. PMC: 8369716. DOI: 10.1186/s13561-021-00329-9. View

16.

Chung K, Kim K, Jung J, Oh K, Oh Y, Kim S . Patterns and determinants of COPD-related healthcare utilization by severity of airway obstruction in Korea. BMC Pulm Med. 2014; 14:27. PMC: 3938473. DOI: 10.1186/1471-2466-14-27. View

17.

Leusder M, Porte P, Ahaus K, van Elten H . Cost measurement in value-based healthcare: a systematic review. BMJ Open. 2023; 12(12):e066568. DOI: 10.1136/bmjopen-2022-066568. View

18.

Silber J, Rosenbaum P, Koziol L, Sutaria N, Marsh R, Even-Shoshan O . Conditional Length of Stay. Health Serv Res. 1999; 34(1 Pt 2):349-63. PMC: 1089006. View

19.

Kim C, Yoo K, Rhee C, Yoon H, Kim Y, Lee S . Health care use and economic burden of patients with diagnosed chronic obstructive pulmonary disease in Korea. Int J Tuberc Lung Dis. 2014; 18(6):737-43. DOI: 10.5588/ijtld.13.0634. View

20.

Anzueto A, Sethi S, Martinez F . Exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2007; 4(7):554-64. DOI: 10.1513/pats.200701-003FM. View